PGA
TEVA icon

Portland Global Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Portland Global Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-37,729
Closed -$664K – 102
2017
Q3 		$664K Sell
37,729
-1,056
-3% -$23.8K 0.25% 57
2017
Q2 		$1.29M Sell
38,785
-200
-0.5% -$6.19K 0.52% 42
2017
Q1 		$1.25M Buy
38,985
+575
+1% +$19.6K 0.52% 42
2016
Q4 		$1.39M Buy
38,410
+2,525
+7% +$101K 0.61% 40
2016
Q3 		$1.65M Sell
35,885
-30
-0.1% -$1.56K 0.73% 33
2016
Q2 		$1.8M Sell
35,915
-385
-1% -$20.5K 0.83% 30
2016
Q1 		$1.94M Sell
36,300
-220
-0.6% -$12.9K 0.93% 27
2015
Q4 		$2.4M Sell
36,520
-990
-3% -$61.2K 1.29% 15
2015
Q3 		$2.12M Sell
37,510
-695
-2% -$45.1K 1.25% 15
2015
Q2 		$2.26M Sell
38,205
-200
-0.5% -$12.3K 1.18% 15
2015
Q1 		$2.39M Sell
38,405
-550
-1% -$32K 1.24% 13
2014
Q4 		$2.24M Sell
38,955
-335
-0.9% -$18.7K 1.15% 15
2014
Q3 		$2.11M Sell
39,290
-160
-0.4% -$8.48K 1.09% 17
2014
Q2 		$2.07M Buy
39,450
+1,730
+5% +$88.4K 1.04% 15
2014
Q1 		$1.99M Sell
37,720
-1,860
-5% -$86K 1.17% 14
2013
Q4 		$1.59M Sell
39,580
-145
-0.4% -$5.71K 0.99% 26
2013
Q3 		$1.5M Sell
39,725
-380
-0.9% -$14.8K 1.01% 23
2013
Q2 		$1.57M Buy
+40,105
New +$1.56M 1.12% 19

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Portland Global Advisors's TEVA Position: Q4 2017 in Review

Portland Global Advisors sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 37,729 shares — an estimated $664K sold.

Portland Global Advisors first reported a position in TEVA in Q2 2013 and held it in 18 quarters. The position peaked at $2.4M in Q4 2015. 507 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • Portland Global Advisors reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Portland Global Advisors sold 37,729 Teva Pharmaceuticals shares in Q4 2017, an estimated $664K.
  • Portland Global Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Portland Global Advisors's Teva Pharmaceuticals position peaked at $2.4M in Q4 2015.
  • 507 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on Portland Global Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.